tiprankstipranks
Trending News
More News >
CleanSpace Holdings Ltd. (AU:CSX)
ASX:CSX
Australian Market
Advertisement

CleanSpace Holdings Ltd. (CSX) AI Stock Analysis

Compare
6 Followers

Top Page

AU

CleanSpace Holdings Ltd.

(Sydney:CSX)

Rating:51Neutral
Price Target:
AU$0.50
▼(-19.35%Downside)
The overall score is impacted primarily by profitability challenges despite strong revenue growth. Technical analysis shows positive momentum but also potential overbought conditions. Valuation is a concern due to negative earnings and lack of dividends.

CleanSpace Holdings Ltd. (CSX) vs. iShares MSCI Australia ETF (EWA)

CleanSpace Holdings Ltd. Business Overview & Revenue Model

Company DescriptionCleanSpace Holdings Limited engages in the design, manufacture, and sale of respirators and related products and services for healthcare and industrial employers worldwide. It offers CleanSpace HALO, a personal respiratory protection for healthcare; CleanSpace ULTRA, a personal respiratory protection for face/eye protection and water tolerance; CleanSpace2, a personal respiratory protection for workers in general industrial environments; and CleanSpace EX for personal protection for people working in explosive environments. The company also provides accessories and consumable products comprising masks, filters, docking stations, cleaning and storage products, car chargers, biohoods, half mask and bio mask exhalation adaptors, unit id panels, mask id badges, mask decal, helmet hook strap, hoods, backpacks, full face mask quantitative fit test, full face mask spectacle kits, visor protectors, head harness, grommet, and spares. It serves mining, welding, construction, laboratory, dental, wastewater, and healthcare and first responder's industries. CleanSpace Holdings Limited was founded in 2009 and is based in St Leonards, Australia.
How the Company Makes MoneyCleanSpace Holdings Ltd. generates revenue primarily through the sale of its respiratory protection products. The company's key revenue streams include direct sales to industrial clients, distribution partnerships with safety equipment suppliers, and online sales through its e-commerce platform. Additionally, CleanSpace may engage in strategic partnerships with healthcare institutions and large industrial companies to secure bulk purchasing agreements. The company's focus on innovation and adherence to safety standards enhances its competitive edge, contributing to sustained demand and market growth.

CleanSpace Holdings Ltd. Financial Statement Overview

Summary
CleanSpace Holdings Ltd. shows strong revenue growth but faces significant challenges with profitability, marked by negative profit margins and cash flow issues. The balance sheet indicates manageable leverage but is offset by declining equity and poor ROE.
Income Statement
45
Neutral
CleanSpace Holdings Ltd. experienced a substantial revenue growth of 29.97% from 2023 to 2024, indicating a positive trajectory. However, the company is struggling with profitability, as evidenced by negative gross profit margins and net profit margins over recent years. EBIT and EBITDA margins also remain negative, highlighting ongoing operational challenges.
Balance Sheet
55
Neutral
The company's balance sheet shows a moderate debt-to-equity ratio, reflecting manageable leverage levels. However, the return on equity (ROE) remains negative due to consistent net losses, indicating poor profitability. The equity ratio is fairly strong, suggesting a solid capital structure, but the decline in stockholders' equity over recent periods is a concern.
Cash Flow
40
Negative
CleanSpace Holdings Ltd. has faced challenges in generating positive operating cash flows, with a negative free cash flow and operating cash flow to net income ratio. Despite these issues, the company managed to significantly reduce its negative free cash flow from 2023 to 2024, showing some improvement in cash management.
BreakdownJun 2024Jun 2023Jun 2022Jun 2021Jun 2020
Income Statement
Total Revenue15.72M12.09M13.36M49.93M28.41M
Gross Profit11.36M-5.16M9.75M40.27M12.77M
EBITDA-3.49M-10.55M-14.00M17.15M7.03M
Net Income-3.13M-8.13M-11.28M11.39M5.92M
Balance Sheet
Total Assets26.05M28.98M38.36M50.72M49.80M
Cash, Cash Equivalents and Short-Term Investments9.76M12.16M24.30M38.24M31.00M
Total Debt3.45M4.00M4.13M4.38M2.40M
Total Liabilities6.95M7.02M8.60M9.99M10.40M
Stockholders Equity19.10M21.96M29.75M40.73M39.40M
Cash Flow
Free Cash Flow-1.76M-11.97M-13.60M11.73M4.31M
Operating Cash Flow-1.73M-11.96M-13.00M13.46M4.71M
Investing Cash Flow2.00M7.06M-628.00K-14.18M-1.94M
Financing Cash Flow-637.10K-211.49K-357.95K16.19M2.17M

CleanSpace Holdings Ltd. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price0.62
Price Trends
50DMA
0.47
Positive
100DMA
0.45
Positive
200DMA
0.44
Positive
Market Momentum
MACD
0.04
Negative
RSI
78.78
Negative
STOCH
97.26
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:CSX, the sentiment is Positive. The current price of 0.62 is above the 20-day moving average (MA) of 0.53, above the 50-day MA of 0.47, and above the 200-day MA of 0.44, indicating a bullish trend. The MACD of 0.04 indicates Negative momentum. The RSI at 78.78 is Negative, neither overbought nor oversold. The STOCH value of 97.26 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AU:CSX.

CleanSpace Holdings Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (57)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
57
Neutral
£4.81B6.73-62.36%5.45%34.03%6.31%
AUCSX
51
Neutral
AU$48.53M-7.59%28.89%72.95%
$54.07M-51.08%
AUEMV
48
Neutral
AU$148.80M-58.61%-74.88%
AUMX1
44
Neutral
AU$32.69M-135.33%-27.58%33.69%
AUCYC
41
Neutral
AU$113.36M-35.20%4.68%-155.42%
AUCBL
39
Underperform
AU$12.37M-98.08%-7.44%30.34%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AU:CSX
CleanSpace Holdings Ltd.
0.66
0.10
17.86%
IPDQF
Impedimed Limited
0.03
-0.04
-57.14%
AU:CYC
Cyclopharm Limited
1.10
-0.58
-34.52%
AU:MX1
Micro-X Ltd.
0.05
-0.03
-37.50%
AU:EMV
EMvision Medical Devices Ltd.
1.78
-0.20
-10.10%
AU:CBL
Control Bionics Ltd.
0.04
-0.01
-20.00%

CleanSpace Holdings Ltd. Corporate Events

CleanSpace Holdings Reports 26% Revenue Growth for FY25
Jul 14, 2025

CleanSpace Holdings Limited reported a 26% increase in revenue for FY25, reaching $19.7 million, driven by strong sales in Europe, North America, and the APAC regions. The company’s focus on industrial markets and strategic expansion, including new sales staff and distribution agreements, has bolstered its market presence. CleanSpace’s innovative respirators continue to gain recognition, and the company is exploring new applications to expand growth opportunities.

CleanSpace Secures $940.8K R&D Tax Incentive for Innovation
Jun 3, 2025

CleanSpace Holdings Limited has received a $940,854 cash rebate from the Australian Federal Government’s R&D Tax Incentive Program for the financial year ending June 2024. This funding will support the company’s ongoing product research and development efforts in the Powered Air Purifying Respirator market, reinforcing its commitment to innovation and leadership in providing advanced respiratory protection solutions for industrial markets.

CleanSpace Holdings Ltd. Announces Quotation of New Securities on ASX
May 30, 2025

CleanSpace Holdings Ltd. has announced the quotation of 79,866 ordinary fully paid securities on the Australian Securities Exchange (ASX), effective May 30, 2025. This move is part of the company’s strategy to enhance liquidity and broaden its investor base, potentially strengthening its market position and offering more opportunities for stakeholders.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jul 16, 2025